These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1820881)

  • 1. Pharmacokinetics of lamotrigine (Lamictal) in plasma and saliva.
    Trnavska Z; Krejcova H; Tkaczykovam ; Salcmanova Z; Elis J
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():211-5. PubMed ID: 1820881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saliva and serum concentration of lamotrigine in patients with epilepsy.
    Tsiropoulos I; Kristensen O; Klitgaard NA
    Ther Drug Monit; 2000 Oct; 22(5):517-21. PubMed ID: 11034255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring salivary lamotrigine concentrations.
    Malone SA; Eadie MJ; Addison RS; Wright AW; Dickinson RG
    J Clin Neurosci; 2006 Nov; 13(9):902-7. PubMed ID: 17049864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in lamotrigine pharmacokinetics during pregnancy and the puerperium.
    Franco V; Mazzucchelli I; Gatti G; Specchio LM; La Neve A; Papantonio A; Ozkaynakçi AE; Perucca E
    Ther Drug Monit; 2008 Aug; 30(4):544-7. PubMed ID: 18641557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of plasma and saliva concentrations of lamotrigine in healthy volunteers.
    Incecayir T; Agabeyoglu I; Gucuyener K
    Arzneimittelforschung; 2007; 57(8):517-21. PubMed ID: 17915637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of an effect of valproate concentration on lamotrigine pharmacokinetics in developmentally disabled patients with epilepsy.
    Gidal BE; Anderson GD; Rutecki PR; Shaw R; Lanning A
    Epilepsy Res; 2000 Nov; 42(1):23-31. PubMed ID: 10996503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics of lamotrigine with data from therapeutic drug monitoring in German and Spanish patients with epilepsy.
    Rivas N; Buelga DS; Elger CE; Santos-Borbujo J; Otero MJ; Domínguez-Gil A; García MJ
    Ther Drug Monit; 2008 Aug; 30(4):483-9. PubMed ID: 18641550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma concentrations of lamotrigine and its 2-N-glucuronide metabolite during pregnancy in women with epilepsy.
    Ohman I; Beck O; Vitols S; Tomson T
    Epilepsia; 2008 Jun; 49(6):1075-80. PubMed ID: 18076642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate, and during lactation.
    Ohman I; Vitols S; Tomson T
    Epilepsia; 2000 Jun; 41(6):709-13. PubMed ID: 10840403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of various antiepileptic drugs on plasma levels of lamotrigine, a novel antiepileptic, in rats.
    Yamashita S; Furuno K; Moriyama M; Kawasaki H; Gomita Y
    Pharmacology; 1997 Jun; 54(6):319-27. PubMed ID: 9286816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A sensitive and selective HPLC method for estimation of lamotrigine in human plasma and saliva: application to plasma-saliva correlation in epileptic patients.
    Mallayasamy SR; Arumugamn K; Jain T; Rajakannan T; Bhat K; Gurumadhavrao P; Devarakonda R
    Arzneimittelforschung; 2010; 60(10):599-606. PubMed ID: 21125809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of dosage, age, and comedication on steady state plasma lamotrigine concentrations in epileptic children: a prospective study with preliminary assessment of correlations with clinical response.
    Bartoli A; Guerrini R; Belmonte A; Alessandrì MG; Gatti G; Perucca E
    Ther Drug Monit; 1997 Jun; 19(3):252-60. PubMed ID: 9200763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of pregnancy and contraception on lamotrigine disposition: new insights through analysis of lamotrigine metabolites.
    Ohman I; Luef G; Tomson T
    Seizure; 2008 Mar; 17(2):199-202. PubMed ID: 18201913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lamotrigine plasma concentrations in children and adults: influence of age and associated therapy.
    Battino D; Croci D; Granata T; Estienne M; Pisani F; Avanzini G
    Ther Drug Monit; 1997 Dec; 19(6):620-7. PubMed ID: 9421101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation in lamotrigine plasma concentrations with hormonal contraceptive monthly cycles in patients with epilepsy.
    Contin M; Albani F; Ambrosetto G; Avoni P; Bisulli F; Riva R; Tinuper P; Baruzzi A
    Epilepsia; 2006 Sep; 47(9):1573-5. PubMed ID: 16981875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors that influence the pharmacokinetics of lamotrigine in Japanese patients with epilepsy.
    Inoue K; Yamamoto Y; Suzuki E; Takahashi T; Umemura A; Takahashi Y; Imai K; Inoue Y; Hirai K; Tsuji D; Itoh K
    Eur J Clin Pharmacol; 2016 May; 72(5):555-62. PubMed ID: 26790665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lamotrigine in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Vos AM; Hulsman J; Lambrechts D; Leenen L; Majoie M; Savelkoul M; Schellekens A; Aldenkamp AP
    Epilepsy Behav; 2008 Feb; 12(2):262-8. PubMed ID: 18093878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steady-state pharmacokinetics of lamotrigine when converting from a twice-daily immediate-release to a once-daily extended-release formulation in subjects with epilepsy (The COMPASS Study).
    Tompson DJ; Ali I; Oliver-Willwong R; Job S; Zhu L; Lemme F; Hammer AE; Vuong A; Messenheimer JA
    Epilepsia; 2008 Mar; 49(3):410-7. PubMed ID: 17825077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of VPA dose and concentration effects on lamotrigine pharmacokinetics: implications for conversion to lamotrigine monotherapy.
    Gidal BE; Sheth R; Parnell J; Maloney K; Sale M
    Epilepsy Res; 2003 Dec; 57(2-3):85-93. PubMed ID: 15013050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An investigation of the influence of patient-related factors and comedications on lamotrigine clearance in patients with epilepsy.
    Baldoni AO; Freitas-Lima P; de Santi Ferreira FI; Martinez EZ; Queiroz RH; Sakamoto AC; Alexandre V; Perucca E; Pereira LR
    Clin Exp Pharmacol Physiol; 2016 Jul; 43(7):685-9. PubMed ID: 27120710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.